Project Grant R03TR004825
Award Date
2/1/25
Completion Date
1/31/26
Dollars Obligated
$159K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA Program 93.859 (Biomedical Research and Research Training) is funding research to advance charge detection-mass spectrometry (CD-MS) technology. The primary objectives are to: 1) Improve the mass resolving power of CD-MS above 300,000 by designing enhanced electrostatic linear ion traps (ELITs) and overcoming alignment challenges, and 2) Substantially reduce the time needed to acquire a CD-MS...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $190,485.00 over the period of February 4, 2025 to January 31, 2030 to Indiana University Indianapolis to investigate the molecular mechanisms underlying differentiation failure in neuroepithelial stem cells with NF2 gene mutations. The goal is to identify the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research program to develop a better understanding of the genomic, epigenomic, and transcriptomic outcomes of gene therapy. The goal is to address long-standing questions about the durability of gene replacement therapy, the adaptive immune response, and unintentional genomic changes including vector integrations. The $367,059...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $487,567 to Indiana University to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects (CHDs). The research aims to identify genetic variants and biological pathways associated with CHDs, as well as build predictive models leveraging genetic, epigenetic,...
This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 Child Health and Human Development Extramural Research, supports the development of high-throughput methodologies to rapidly measure and optimize in vivo adeno-associated virus (AAV)-mediated homology directed repair (HDR) gene editing efficiency in mice. The $425,348 award to Indiana University Indianapolis, a research-intensive state university, aims to create novel...
This Project Grant award of $412,525 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research focused on understanding the molecular mechanisms that regulate ADAR target recognition and RNA editing. The research, led by the Hundley Lab at Indiana University, aims to define the structural elements and sequences recognized by ADAR RNA binding proteins, and investigate how transcription, cellular...
This Project Grant award, with a total funding of $158,500.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports an investigation into redox signaling as a potential therapeutic target for malignant peripheral nerve sheath tumors (MPNST). The ultimate period of performance for this grant is from July 1, 2024 to June 30, 2026. The grant recipient is the Trustees of Indiana University, doing business as Indiana...
The U.S. Department of Health and Human Services, National Institute of General Medical Sciences awarded a $330,025 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Nebraska Medical Center. The funding supports the development of prototype genetically engineered mouse models to investigate the potential of the SEND-based mRNA delivery system for gene therapy applications. The project aims to create mouse models that can produce...